EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of sodium‐glucose cotransporter‐2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model

Jintao Wang iD, Paul Silaghi, Chiao Guo, David Harro, Daniel T Eitzman

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Jintao Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cardiovascular Research Center, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Sodium-Glucose Transporter 2 Inhibitors, Disease Models, Animal, Benzhydryl Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Michigan Pandemic Relief grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium‐glucose cotransporter‐2 (SGLT‐2) is expressed in the kidney and may contribute to anaemia and cardiovascular diseases. The effect of SGLT‐2 inhibition on anaemia and vascular endpoints in sickle cell disease (SCD) is unknown. A murine model of SCD was studied to determine the effects of the SGLT‐2 inhibitor, empagliflozin, on anaemia and stroke size. The University of Michigan's Precision Health Database was used to evaluate the effect of SGLT‐2 inhibitors on anaemia in humans with SCD. SCD mice treated with daily empagliflozin for 8 weeks demonstrated increases in haemoglobin, haematocrit, erythrocyte counts, reticulocyte percentage and erythropoietin compared to vehicle‐treated mice. Following photochemical‐induced thrombosis of the middle cerebral artery, mice treated with empagliflozin demonstrated reduced stroke size compared to vehicle treated mice. In the electronic health records analysis, haemoglobin, haematocrit and erythrocyte counts increased in human SCD subjects treated with an SGLT‐2 inhibitor. SGLT‐2 inhibitor treatment of humans and mice with SCD is associated with improvement in anaemic parameters. Empagliflozin treatment is also associated with reduced stroke size in SCD mice suggesting SGLT‐2 inhibitor treatment may be beneficial with regard to both anaemia and vascular complications in SCD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellSodium-Glucose Transporter 2 InhibitorsDisease Models, AnimalBenzhydryl CompoundsGlucosidesStrokeAnemiaAnimalsHumansMiceMaleFemaleSodium-Glucose Transporter 2Mice, Inbred C57BL

Substanzen

Sodium-Glucose Transporter 2 InhibitorsempagliflozinBenzhydryl CompoundsGlucosidesSodium-Glucose Transporter 2

Autor:innen und Institutionen

  • Department of Internal Medicine, Cardiovascular Research Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Chemical Pathology, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: Jintao Wang

Förderung

  • University of Michigan Pandemic Relief grant

Zitieren

APA

Wang, J., Silaghi, P., Guo, C., Harro, D., & Eitzman, D. T. (2024). Inhibition of sodium‐glucose cotransporter‐2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70091

Vancouver

Wang J, Silaghi P, Guo C, Harro D, Eitzman DT. Inhibition of sodium‐glucose cotransporter‐2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70091

BibTeX
@article{Wang2024,
  author = {Wang, Jintao and Silaghi, Paul and Guo, Chiao and Harro, David and Eitzman, Daniel T},
  title = {Inhibition of sodium‐glucose cotransporter‐2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70091}
}
Kostenlos starten →